Search results
Results from the WOW.Com Content Network
The devices contain a fixed dose of epinephrine and a spring-loaded needle (or, in the case of AuviQ, a CO 2-driven needle) that exits the tip or edge of the device and penetrates the recipient's skin, to deliver the medication via intramuscular injection. [2] People to whom epinephrine autoinjectors are prescribed need to be trained how to use ...
Epinephrine, also known as adrenaline, is a medication and hormone. [10] [11] As a medication, it is used to treat several conditions, including anaphylaxis, cardiac arrest, asthma, and superficial bleeding. [8] Inhaled epinephrine may be used to improve the symptoms of croup. [12] It may also be used for asthma when other treatments are not ...
Often these treatments include an antihistamine oral pill, nasal spray, or eye drops. Other treatments include an allergy shot, which keep the allergic response to a minimum. For more severe reactions an epinephrine injection is carried around. This injection will be taken if the person is going into anaphylactic shock. The best treatment is ...
That is why the field has long pursued an effective treatment approach that does not require an injection.” ARS Pharmaceuticals said in a call with investors that the list price for a two-pack ...
These include antihistamines, glucocorticoids, epinephrine (adrenaline), mast cell stabilizers, and antileukotriene agents are common treatments of allergic diseases. [130] Anticholinergics , decongestants , and other compounds thought to impair eosinophil chemotaxis are also commonly used.
Cromolyn Nedocromil. Mast cell stabilizers are medications used to prevent or treat certain allergic disorders. They block mast cell degranulation, stabilizing the cell and thereby preventing the release of histamine and related mediators.
WARREN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today commented on the approval of a non-injection-based device for delivery of epinephrine for the treatment of ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. More and more treatment options are becoming available for obesity and overweight. This includes type 2 diabetes drugs and weight ...